Fig. 1From: Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trialProportion of patients who had a MAP response at hour 3 by their angiotensin II dose, at 30 min following study initiation; > 5 ng kg−1 min−1 versus ≤ 5 ng kg−1 min−1 (a). Proportion of patients who had a MAP response at hour 3 by their angiotensin II dose at 30 min and quartiles of baseline angiotensin II (b). CI, confidence interval; MAP, mean arterial pressureBack to article page